InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Explore the complete record of transactions filed by Saad Mark E, Director. Director active across 1 companies, notably Axsome Therapeutics, Inc.. Cumulatively, 2 disclosures have been logged. Total volume traded: €183k. The latest transaction was disclosed on 17 November 2021 (Acquisition). Regulator: SEC (Form 4). All data is free.
Declarations2 total
€91,5073,000 shares@ €30.5025100.0% of flow
Common Stock
SEC:0001209191-21-065696·
Ideal exit: 14 Aug 2022 (T+270)
€91,5073,000 shares@ €30.50250.0010% mcap50.0% of flow
Common Stock
SEC:0001209191-21-065696:0·
Ideal exit: 14 Aug 2022 (T+270)
2 of 2 declarations
About Saad Mark E
Saad Mark E is a Board Member of Axsome Therapeutics, Inc. He plays a key role in the governance of the company, contributing to strategic decision-making and oversight of operations. His experience in the pharmaceutical sector is an asset for Axsome Therapeutics, which focuses on developing innovative treatments.
